Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain

The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akiko Eto, Norio Yamamoto, Yasuhiro Kanatani
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c076bebff9cb4efaaa2aa2fcdc9bf4c2
record_format dspace
spelling oai:doaj.org-article:c076bebff9cb4efaaa2aa2fcdc9bf4c22021-11-25T16:47:33ZEffect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain10.3390/biology101111582079-7737https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c22021-11-01T00:00:00Zhttps://www.mdpi.com/2079-7737/10/11/1158https://doaj.org/toc/2079-7737The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccine that was developed and licensed in Japan in the 1970s. LC16m8 was obtained by the passaging of Lister strain, with indicators of small plaque formation and temperature sensitivity as virus phenotypes. This strain can replicate in mammalian cells and provides robust cellular and humoral immunity, as well as long-term immune memory. Recent studies using proteome-wide antigen arrays have revealed that antibody production against LC16m8 and other VACVs differs largely among individuals. Moreover, associations between SNPs in immune-related genes and immune outcomes have been increasingly found. These results lead to predicting adverse events of a vaccine, which is a purpose of vaccinomics. Studies on VACV will continue to contribute to the understanding of host-pathogen interactions and to development of a vaccine for other infectious and non-infectious diseases. Here, we review studies of VACV, including our recent research on LC16m8, with a focus on the phenotype and genotype, and we discuss future research directions.Akiko EtoNorio YamamotoYasuhiro KanataniMDPI AGarticlevaccinia virusvaccineLC16m8immune responsehumoral immunityinterindividual differenceBiology (General)QH301-705.5ENBiology, Vol 10, Iss 1158, p 1158 (2021)
institution DOAJ
collection DOAJ
language EN
topic vaccinia virus
vaccine
LC16m8
immune response
humoral immunity
interindividual difference
Biology (General)
QH301-705.5
spellingShingle vaccinia virus
vaccine
LC16m8
immune response
humoral immunity
interindividual difference
Biology (General)
QH301-705.5
Akiko Eto
Norio Yamamoto
Yasuhiro Kanatani
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
description The phenotype of an attenuated live vaccine depends on gene mutation achieved by, for example, many passages in cultured cells. Viral clones with preferable phenotypes are selected and the causative genetic mutation(s) are later identified. LC16m8 is an example of a highly attenuated smallpox vaccine that was developed and licensed in Japan in the 1970s. LC16m8 was obtained by the passaging of Lister strain, with indicators of small plaque formation and temperature sensitivity as virus phenotypes. This strain can replicate in mammalian cells and provides robust cellular and humoral immunity, as well as long-term immune memory. Recent studies using proteome-wide antigen arrays have revealed that antibody production against LC16m8 and other VACVs differs largely among individuals. Moreover, associations between SNPs in immune-related genes and immune outcomes have been increasingly found. These results lead to predicting adverse events of a vaccine, which is a purpose of vaccinomics. Studies on VACV will continue to contribute to the understanding of host-pathogen interactions and to development of a vaccine for other infectious and non-infectious diseases. Here, we review studies of VACV, including our recent research on LC16m8, with a focus on the phenotype and genotype, and we discuss future research directions.
format article
author Akiko Eto
Norio Yamamoto
Yasuhiro Kanatani
author_facet Akiko Eto
Norio Yamamoto
Yasuhiro Kanatani
author_sort Akiko Eto
title Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
title_short Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
title_full Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
title_fullStr Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
title_full_unstemmed Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
title_sort effect of serial passage on the pathogenicity and immunogenicity of vaccinia virus lc16m8 strain
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c076bebff9cb4efaaa2aa2fcdc9bf4c2
work_keys_str_mv AT akikoeto effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain
AT norioyamamoto effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain
AT yasuhirokanatani effectofserialpassageonthepathogenicityandimmunogenicityofvacciniaviruslc16m8strain
_version_ 1718412980617478144